Malignant Hyperthermia (MH)
Signs (early)
-
↑ EtCO2
-
Tachycardia
-
Tachypnea
-
Mixed acidosis
-
Masseter spasm/trismus
-
Sudden cardiac arrest due to hyperkalemia
Signs (may be later)
-
Hyperthermia
-
Muscle rigidity
-
Myoglobinuria
-
Arrhythmias
-
Cardiac arrest
Differential Diagnosis
-
Neuroleptic malignant syndrome: similar presentation to MH but associated with use of antipsychotic neuroleptic medications (also treated with dantrolene)
-
Thyroid storm: fever, tachycardia, altered mental status
-
Anaphylaxis: cardiovascular collapse without hypermetabolic features
-
Pheochromocytoma: significant hypertension
-
Drug toxicity: consider clinical context, screen urine/plasma
Management
-
Alert surgeon & call for help
-
Stop anesthetic triggers (volatiles & succinylcholine), ↑ fresh gas flow to 10L/min; do not change machine or circuit
-
If available, insert activated charcoal filters into the inspiratory & expiratory limbs of the breathing circuit
-
↑ to 100% FiO2 & ↑ minute ventilation
-
Halt surgery; if emergent, continue with non-triggering anesthetic
-
Call MH hotline:
-
MHAUS (Malignant Hyperthermia Association of the United States)
-
1 800 644 9737 (within USA); 00 1 209 417 3722 (outside USA)
-
-
-
Assign several people to prepare dantrolene 2.5 mg/kg IV bolus:
-
Dilute each 20 mg dantrolene vial in 60 mL preservative-free sterile water
-
For 70 kg person, give 175 mg (prepare 9 vials of 20 mg dantrolene)
-
Rapidly administer dantrolene & continue giving until patient stable
-
May need > 10 mg/kg
-
-
Cool patient: IV fluids, ice packs, gastric / peritoneal lavage
-
Treat arrhythmias:
-
Usually secondary to hyperkalemia
-
Treat in standard fashion, however avoid calcium channel blockers
-
-
Treat metabolic acidosis:
-
Sodium bicarbonate 1 to 2mEq/kg PRN for base excess greater than -8
-
-
Treat hyperkalemia:
-
Hyperventilation
-
Calcium chloride 10mg/kg (max dose 2g) or calcium gluconate 30mg/kg (max 3g)
-
D50 1 amp IV (25g dextrose) + regular insulin 10 units IV → monitor glucose
-
Sodium bicarbonate 1 amp
-
Furosemide 0.5-1mg/kg once
-
For refractory hyperkalemia, consider beta-agonist, kayexalate, dialysis, or ECMO if in cardiac arrest
-
-
Monitor temperature, electrolytes, arterial/venous blood gases, creatine kinase, urine output, coagulation studies, lactic acid
-
Place foley catheter, monitor urine output
-
When stable, transfer to post anesthesia care unit or intensive care unit for at least 24 hours
-
Monitor for recurrence & continue dantrolene 1 mg/kg q 4-6 hours x 24 to 48 hours
-
Refer for genetic counseling/in-vitro muscle contracture testing